Wells Fargo’s MDxHealth MDXH Stock Holding History

Wells Fargo’s Portfolio MDXH Stock Details MDXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82	Hold	200	–	–	﹤0.01%	6663
2026 Q1	$460	Hold	200	–	–	﹤0.01%	6403
2025 Q4	$714	Hold	200	–	–	﹤0.01%	6311
2025 Q3	$930	Hold	200	–	–	﹤0.01%	6262
2025 Q2	$442	Hold	200	–	–	﹤0.01%	6388
2025 Q1	$284	Hold	200	–	–	﹤0.01%	6310
2024 Q4	$474	Buy	+200	New	+$409	﹤0.01%	6314

Other funds holding MDXH

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Wells Fargo's MDXH Position: Q2 2026 in Review

Wells Fargo held its MDxHealth (MDXH) position steady in Q2 2026 at 200 shares worth $82. The position accounts for ﹤0.01% of the portfolio, ranked #6663.

Wells Fargo first reported a position in MDXH in Q4 2024 and has held it in 7 quarters since. The position peaked at $930 in Q3 2025. 26 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

Wells Fargo held 200 shares of MDxHealth worth $82 as of Q2 2026.
Wells Fargo left its MDxHealth share count unchanged in Q2 2026.
MDxHealth made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6663 holding.
Wells Fargo first reported a position in MDxHealth in Q4 2024 and has held it in 7 quarters since.
Wells Fargo's MDxHealth position peaked at $930 in Q3 2025.
26 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.